This statistic shows the top products of biopharmaceutical company Gilead Sciences from 2022 to 2024, based on revenue. Gilead Sciences Inc. is headquartered in California and is specialized in discovering, developing and commercializing therapeutics. In 2024, Gilead Sciences' COVID-19 treatment Veklury (remdesivir) generated some 1.8 billion U.S. dollars in revenue, a significant decrease compared to 5.6 billion in 2021.
Advertisement
Advertisement
Leading products of Gilead Sciences from 2022 to 2024 based on revenue
(in million U.S. dollars)
* Represents our revenue from cobicistat (“C”), emtricitabine (“FTC”) and tenofovir alafenamide (“TAF”) in Symtuza (darunavir/C/FTC/TAF), a fixed dose combination product commercialized by Janssen Sciences Ireland Unlimited Company (“Janssen”).
Profit from the additional features of your individual account
Currently, you are using a shared account. To use individual functions (e.g., mark statistics as favourites, set
statistic alerts) please log in with your personal account.
If you are an admin, please authenticate by logging in again.
Learn more about how Statista can support your business.
Gilead Sciences, & U.S. Securities and Exchange Commission. (February 26, 2025). Leading products of Gilead Sciences from 2022 to 2024 based on revenue (in million U.S. dollars) [Graph]. In Statista. Retrieved June 27, 2025, from https://www.statista.com/statistics/274509/top-products-of-gilead-sciences-based-on-revenue/
Gilead Sciences, und U.S. Securities and Exchange Commission. "Leading products of Gilead Sciences from 2022 to 2024 based on revenue (in million U.S. dollars)." Chart. February 26, 2025. Statista. Accessed June 27, 2025. https://www.statista.com/statistics/274509/top-products-of-gilead-sciences-based-on-revenue/
Gilead Sciences, U.S. Securities and Exchange Commission. (2025). Leading products of Gilead Sciences from 2022 to 2024 based on revenue (in million U.S. dollars). Statista. Statista Inc.. Accessed: June 27, 2025. https://www.statista.com/statistics/274509/top-products-of-gilead-sciences-based-on-revenue/
Gilead Sciences, and U.S. Securities and Exchange Commission. "Leading Products of Gilead Sciences from 2022 to 2024 Based on Revenue (in Million U.S. Dollars)." Statista, Statista Inc., 26 Feb 2025, https://www.statista.com/statistics/274509/top-products-of-gilead-sciences-based-on-revenue/
Gilead Sciences & U.S. Securities and Exchange Commission, Leading products of Gilead Sciences from 2022 to 2024 based on revenue (in million U.S. dollars) Statista, https://www.statista.com/statistics/274509/top-products-of-gilead-sciences-based-on-revenue/ (last visited June 27, 2025)
Leading products of Gilead Sciences from 2022 to 2024 based on revenue (in million U.S. dollars) [Graph], Gilead Sciences, & U.S. Securities and Exchange Commission, February 26, 2025. [Online]. Available: https://www.statista.com/statistics/274509/top-products-of-gilead-sciences-based-on-revenue/
